Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Frigo

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
JCO Oncology Practice|November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone TherapyNeha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
The Journal of Urology|February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort StudyTarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
Cell Reports|June 8, 2025
Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancerChenchu Lin, Thomas L Pulliam, Jenny J Han, et al.
Prostate Cancer and Prostatic Diseases|July 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibitionAndrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, et al.
Cell Reports|March 1, 2016
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast CancerJun Hyoung Park, Sajna Vithayathil, Santosh Kumar, et al.
Cells|January 21, 2023
SGC-CAMKK2-1: A Chemical Probe for CAMKK2Carrow Wells, Yi Liang, Thomas L Pulliam, et al.
Journal of Medicinal Chemistry|July 15, 2021
Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor ChemotypesBenjamin J Eduful, Sean N O'Byrne, Louisa Temme, et al.
Cancer Research|December 1, 2023
Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic PlasticityDominik Awad, Pham Hong Anh Cao, Thomas L Pulliam, et al.
Iscience|June 15, 2026
Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancersElavarasan Subramani, Patrick G Pilié, Rebecca Slack-Tidwell, et al.
Nature Communications|May 20, 2016
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancerAkash K Kaushik, Ali Shojaie, Katrin Panzitt, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
JCO Oncology Practice|November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone TherapyNeha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
The Journal of Urology|February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort StudyTarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
Cell Reports|June 8, 2025
Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancerChenchu Lin, Thomas L Pulliam, Jenny J Han, et al.
Prostate Cancer and Prostatic Diseases|July 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibitionAndrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, et al.
Cell Reports|March 1, 2016
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast CancerJun Hyoung Park, Sajna Vithayathil, Santosh Kumar, et al.
Cells|January 21, 2023
SGC-CAMKK2-1: A Chemical Probe for CAMKK2Carrow Wells, Yi Liang, Thomas L Pulliam, et al.
Journal of Medicinal Chemistry|July 15, 2021
Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor ChemotypesBenjamin J Eduful, Sean N O'Byrne, Louisa Temme, et al.
Cancer Research|December 1, 2023
Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic PlasticityDominik Awad, Pham Hong Anh Cao, Thomas L Pulliam, et al.
Iscience|June 15, 2026
Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancersElavarasan Subramani, Patrick G Pilié, Rebecca Slack-Tidwell, et al.
Nature Communications|May 20, 2016
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancerAkash K Kaushik, Ali Shojaie, Katrin Panzitt, et al.
Pageof 8